Skip Navigation

Cardiovascular Research 2001 51(3):592-600; doi:10.1016/S0008-6363(01)00242-5
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Padilla, F.
Right arrow Articles by Soler-Soler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Padilla, F.
Right arrow Articles by Soler-Soler, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs

Ferran Padillaa, David Garcia-Doradoa,*, Luis Agullóa, José A Barrabésa, Javier Insertea, Noelia Escalonaa, Markus Meyerb, Maribel Mirabeta, Pilar Pinaa and Jordi Soler-Solera

aDepartment of Cardiology, Hospital General Universitari Vall d'Hebron, Pg. Vall d'Hebron 119–129, Barcelona 08035, Spain
bNiedersächsiches Institut für Peptide-Forschung (IPF), Hannover, Germany

* Corresponding author. Tel.: +34-93-489-4038; fax: +34-93-489-4032 dgdorado{at}hg.vhebron.es

Objective: It has been shown that cGMP content is reduced in post-ischemic myocardium, and that stimulation of cGMP synthesis prevents cardiomyocyte hypercontracture and cell death in vitro. This study was aimed at determining whether administration of the natriuretic peptide urodilatin (URO) at the time of reperfusion could limit myocardial cell death secondary to transient coronary occlusion. Methods: The relation between cGMP content in reperfused myocardium and the extent of cell death was investigated in isolated rat hearts (n=62) receiving different URO concentrations during initial reperfusion. The dose of intravenous URO necessary to obtain the targeted increase in cGMP in reperfused myocardium was investigated in ten pigs submitted to transient coronary occlusion (CO), and the effect of two selected doses of URO on infarct size was investigated in 22 pigs. Results: cGMP was severely reduced in post-ischemic rat hearts. Addition of 0.01 µM URO during the first 15 min of reperfusion had no effect on myocardial cGMP content, functional recovery or LDH release in hearts submitted to 40 or 60 min of ischemia. At 0.05 µM, URO increased myocardial cGMP to 111% of values in normoxic hearts, improved functional recovery (P=0.01) and reduced peak LDH released by 40% (P=0.02). The beneficial effect of urodilatin was abolished by ANP receptor inhibition. At 1 µM, URO increased cGMP in reperfused myocardium to 363% of normoxic controls and had no beneficial effect. In pigs allocated to 47 min of CO and 5 min of reperfusion, cGMP was markedly reduced in reperfused myocardium. Intravenous URO at 10 ng/kg per min during the first 25 min of reperfusion normalized myocardial cGMP after 5 min of reflow (95% of control myocardium), and reduced infarct size by 40% (P=0.04). At 50 ng/kg per min, urodilatin increased myocardial cGMP in reperfused myocardium to 335% of control myocardium and failed to significantly reduce infarct size (46 vs. 66%, P=0.125). None of these doses had detectable hemodynamic effects. Conclusions: Intravenous low-dose URO at the time of reperfusion normalizes myocardial cGMP and limits necrosis. Large doses of URO increasing myocardial cGMP well over normal values may lack this beneficial effect.

KEYWORDS Ischemia; Natriuretic peptide; Necrosis; Reperfusion; Second messengers


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. Inserte, J. A. Barrabes, V. Hernando, and D. Garcia-Dorado
Orphan targets for reperfusion injury
Cardiovasc Res, July 15, 2009; 83(2): 169 - 178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Kuno, N. V. Solenkova, V. Solodushko, T. Dost, Y. Liu, X.-M. Yang, M. V. Cohen, and J. M. Downey
Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1288 - H1295.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. M. Piper, Y. Abdallah, S. Kasseckert, and K.-D. Schluter
Sarcoplasmic reticulum-mitochondrial interaction in the mechanism of acute reperfusion injury
Cardiovasc Res, January 15, 2008; 77(2): 234 - 236.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, H. M. Piper, and D. A. Eisner
Sarcoplasmic reticulum and mitochondria in cardiac pathophysiology
Cardiovasc Res, January 15, 2008; 77(2): 231 - 233.
[Full Text] [PDF]


Home page
J Intensive Care MedHome page
E. P. Rivers, J. McCord, R. Otero, G. Jacobsen, and M. Loomba
Clinical Utility of B-Type Natriuretic Peptide in Early Severe Sepsis and Septic Shock
J Intensive Care Med, November 1, 2007; 22(6): 363 - 373.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
T. Nishikimi, N. Maeda, and H. Matsuoka
The role of natriuretic peptides in cardioprotection
Cardiovasc Res, February 1, 2006; 69(2): 318 - 328.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, M. Mirabet, J. Inserte, and J. Soler-Soler
Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes
Cardiovasc Res, October 1, 2005; 68(1): 65 - 74.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H.M Piper, Y Abdallah, and C Schafer
The first minutes of reperfusion: a window of opportunity for cardioprotection
Cardiovasc Res, February 15, 2004; 61(3): 365 - 371.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schulz, M. Kelm, and G. Heusch
Nitric oxide in myocardial ischemia/reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 402 - 413.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Sangawa, K. Nakanishi, K. Ishino, M. Inoue, M. Kawada, and S. Sano
Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart
Ann. Thorac. Surg., January 1, 2004; 77(1): 233 - 237.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Agullo, D. Garcia-Dorado, N. Escalona, M. Ruiz-Meana, J. Inserte, and J. Soler-Soler
Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2170 - H2176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. D'Souza, D. M. Yellon, C. Martin, R. Schulz, G. Heusch, A. Onody, P. Ferdinandy, and G. F. Baxter
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1592 - H1600.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. M. Piper, K. Meuter, and C. Schafer
Cellular mechanisms of ischemia-reperfusion injury
Ann. Thorac. Surg., February 1, 2003; 75(2): S644 - 648.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Agullo, D. Garcia-Dorado, N. Escalona, J. Inserte, M. Ruiz-Meana, J. A. Barrabes, M. Mirabet, P. Pina, and J. Soler-Soler
Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H917 - H925.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, M. Ruiz-Meana, F. Padilla, A. Rodriguez-Sinovas, and M. Mirabet
Gap junction-mediated intercellular communication in ischemic preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 456 - 465.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.